Laboratory analysis
From research to diagnosis: the laboratory where quality and reliability merge.
Anti-Ku Antibodies
Test for the determination of human antibodies of the immunoglobulin class G against the nuclear heterodimer Ku (anti-Ku), to support the diagnosis of systemic autoimmune rheumatic diseases (SARD), particularly overlap syndromes.
Anti-Ks Antibodies
Test for the determination of human antibodies of the immunoglobulin class G against asparaginyl-tRNA synthetase (anti-Ks), to support the diagnosis of systemic autoimmune rheumatic diseases (SARD), particularly in myositis.
Anti-Jo-1 Antibodies
Test for the determination of anti-Jo-1 human antibodies of the immunoglobulin class G targeting histidyl-tRNA synthetase, to support the diagnosis of systemic autoimmune rheumatic diseases (SARDs), particularly idiopathic inflammatory myopathies (IIM).
Anti-histone antibodies
Test for the determination of human antibodies of the immunoglobulin class G against histones, to support the diagnosis of systemic autoimmune rheumatic diseases (SARD).
Anti–IA-2A antibodies
Test for the determination of human antibodies of the immunoglobulin class G against a protein-tyrosine phosphatase on pancreatic β-cells (IA-2A), to support the diagnosis of type 1 diabetes.
Anti-Ha Antibodies
Test for the determination of human antibodies of the immunoglobulin class G against tyrosyl-tRNA synthetase (anti-Ha), to support the diagnosis of systemic autoimmune rheumatic diseases (SARD), particularly in myositis.
Anti–Deamidated Gliadin (DGP) IgG Antibodies
Test for the determination of human antibodies of the immunoglobulin class G against deamidated gliadin (anti-DGP), to support the diagnosis of coeliac disease.
Anti–GAD antibodies
Test for the determination of human antibodies of the immunoglobulin class G against glutamic acid decarboxylase (GAD), to support the diagnosis of type 1 diabetes.
laboratory
From research to diagnosis: the laboratory where quality and reliability merge.
Discover what’s new
Subscribe to the newsletter
Subscribe to our newsletter to be always updated.